TARGETING JATROPHA DERIVED PHYTOCHEMICALS TO INHIBIT THE XANTHINE OXIDASE & CYCLOOXYGENASE-2: IN SILICO ANALYSIS TOWARDS GOUT TREATMENT

Authors

  • Satabdee Mohapatra , National Institute of Technology, Rourkela
  • Prajna Kabiraj , National Institute of Technology, Rourkela
  • Tarun Agarwal , National Institute of Technology, Rourkela
  • Somya Asthana , National Institute of Technology, Rourkela
  • Nithyanan Annamalai Universiti Sains Malaysia
  • Hasni Arsad Universiti Sains Malaysia
  • Mohammed Haris Siddiqui Department of Bio-engineering, Integral University, Lucknow, Uttar pradesh
  • Asif Khursheed Department of Bio-engineering, Integral University, Lucknow, Uttar pradesh

Keywords:

Gout, Xanthine Oxidase, Cyclooxygenase-2, Jatropha, Phytochemicals, Autodock 42

Abstract

Objective: Gouty arthritis is a well known disease with an abrupt attack causing extreme pain in and around the joints. Accumulated urate crystals, being the reason of the disease cause a lot of inflammation leading to swelling in the joints. These diseases are being treated using NSAIDs, Colchicine as well as few of the Glucocorticoids but these have some unnatural effects primarily, gastrointestinal and cardiovascular side effects. Nowadays, Jatropha curcas, a medicinal plant has been studied for anti – inflammatory properties therefore the phytochemical constituents of this plant can be an effective drug against this Gout disease.

Methods: Herein for docking, Lamarckian Genetic algorithm was applied using Autodock4.2 (version 1.5.6). Xanthine Oxidase and Cyclooxygenase-2 proteins from Homo sapiens were modeled using the Swiss model and screened against the phytochemicals from Jatropha species.

Results: The results demonstrated that Jatrophone (KNApSAcK_ID: C00003446), 6β-hydroxy-4-stigmasten-3-one (KNApSAcK_ID: C00029573) and Palmarumycin CP1 (KNApSAcK_ID: C00035859) had a good affinity for both, Xanthine oxidase and COX-2. Further, the interaction profile of the phytochemicals with both the protein was analyzed using LigPlot+.

Conclusion: The interaction pattern phytochemicals with the Xanthine Oxidase and Cyclooxygensae-2 may provide hints for the design of novel derivatives with higher potency and specificity.

Downloads

Download data is not yet available.

Author Biography

Asif Khursheed, Department of Bio-engineering, Integral University, Lucknow, Uttar pradesh

Department Of Bioengineering, Assistant Professor

References

Singh JA, Strand V. Gout is associated with more comorbidities, poorer health-related quality of life and higher healthcare utilisation in US veterans. Ann Rheum Dis 2008;67:1310-6.

Lee SJ, Hirsch JD, Terkeltaub R, Khanna D, Singh JA, Sarkin A, et al. Perceptions of disease and health-related quality of life among patients with gout. Rheum 2009;48:582-6.

Ortiz EB, Sieck MS, Ralph Schumacher H. Changes in the proteins coating monosodium urate crystals during active and subsiding inflammation. Immunogold studies of synovial fluid from patients with gout and of fluid obtained using the rat subcutaneous air pouch model. Arthritis Rheum 1993;36:1274-85.

Cherian PV, Schumacher HR. Immunochemical and ultrastructural characterization of serum proteins associated with monosodium urate crystals (MSU) in synovial fluid cells from patients with gout. Ultrastruct Pathol 1986;10:209-19.

Watts R. Uric acid production with particular reference to the role of xanthine oxidase and its inhibition. Proc R Soc Med 1966;59:287.

Pouliot M, James MJ, McColl SR, Naccache PH, Cleland LG. Monosodium urate microcrystals induce cyclooxygenase-2 in human monocytes. Blood 1998;91:1769-76.

Ricciotti E, FitzGerald GA. Prostaglandins and inflammation. Arterioscler Thromb Vasc Biol 2011;31:986-1000.

Martinon F, Pétrilli V, Mayor A, Tardivel A, Tschopp J. Gout-associated uric acid crystals activate the NALP3 inflammasome. Nat 2006;440:237-41.

Rhen T, Cidlowski JA. Antiinflammatory action of glucocorticoids—new mechanisms for old drugs. N Engl J Med 2005;353:1711-23.

Salvo F, Fourrier-Reglat A, Bazin F, Robinson P, Riera-Guardia N, Haag M, et al. Cardiovascular and gastrointestinal safety of NSAIDs: a systematic review of meta-analyses of randomized clinical trials. Clin Pharmacol Ther 2011;89:855-66.

Edwards NL. The role of hyperuricemia and gout in kidney and cardiovascular disease. Cleve Clin J Med 2008;75:S13-S6.

Schäcke H, Döcke W-D, Asadullah K. Mechanisms involved in the side effects of glucocorticoids. Pharmacol Ther 2002;96:23-43.

Prasad DR, Izam A, Khan MMR. Jatropha curcas: plant of medical benefits. J Med Plants Res 2012;6:2691-9.

Carels N. Jatropha curcas: a review. Adv Bot Res 2009;50:39-86.

Agarwal T, Asthana S, Gupta P, Khursheed A. In Silico Study to elucidate inhibitory effect of thiazides on plasmepsins: implications of new antimalarial drug design. Int J Pharm Pharm Sci 2014;6(2):379-82.

Asthana S, Agarwal T, Khursheed A, Dutta D. Molecular modeling and QSAR analysis to explore therapeutic potentials of phytoestrogens in Osteoporosis. Int J Pharm Pharm Sci 2014;6:239-43.

Published

01-01-2015

How to Cite

Mohapatra, S., P. Kabiraj, T. Agarwal, S. Asthana, N. Annamalai, H. Arsad, M. H. Siddiqui, and A. Khursheed. “TARGETING JATROPHA DERIVED PHYTOCHEMICALS TO INHIBIT THE XANTHINE OXIDASE & CYCLOOXYGENASE-2: IN SILICO ANALYSIS TOWARDS GOUT TREATMENT”. International Journal of Pharmacy and Pharmaceutical Sciences, vol. 7, no. 1, Jan. 2015, pp. 360-3, https://journals.innovareacademics.in/index.php/ijpps/article/view/3784.

Issue

Section

Original Article(s)

Most read articles by the same author(s)